165 related articles for article (PubMed ID: 25548082)
1. [¹²³I]ICF01012 melanoma imaging and [¹³¹I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma models.
Viallard C; Perrot Y; Boudhraa Z; Jouberton E; Miot-Noirault E; Bonnet M; Besse S; Mishellany F; Cayre A; Maigne L; Rbah-Vidal L; D'Incan M; Cachin F; Chezal JM; Degoul F
Eur J Dermatol; 2015; 25(1):29-35. PubMed ID: 25548082
[TBL] [Abstract][Full Text] [Related]
2. Anti-melanoma efficacy of internal radionuclide therapy in relation to melanin target distribution.
Bonnet M; Mishellany F; Papon J; Cayre A; Penault-Llorca F; Madelmont JC; Miot-Noirault E; Chezal JM; Moins N
Pigment Cell Melanoma Res; 2010 Oct; 23(5):e1-11. PubMed ID: 20444199
[TBL] [Abstract][Full Text] [Related]
3. Radiation dosimetry of [
Jouberton E; Perrot Y; Dirat B; Billoux T; Auzeloux P; Cachin F; Chezal JM; Filaire M; Labarre P; Miot-Noirault E; Millardet C; Valla C; Vidal A; Degoul F; Maigne L
Med Phys; 2018 Nov; 45(11):5251-5262. PubMed ID: 30179267
[TBL] [Abstract][Full Text] [Related]
4. Targeted radionuclide therapy of melanoma: anti-tumoural efficacy studies of a new 131I labelled potential agent.
Bonnet-Duquennoy M; Papon J; Mishellany F; Labarre P; Guerquin-Kern JL; Wu TD; Gardette M; Maublant J; Penault-Llorca F; Miot-Noirault E; Cayre A; Madelmont JC; Chezal JM; Moins N
Int J Cancer; 2009 Aug; 125(3):708-16. PubMed ID: 19437532
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of [
Thivat E; Rouanet J; Auzeloux P; Sas N; Jouberton E; Levesque S; Billoux T; Mansard S; Molnar I; Chanchou M; Fois G; Maigne L; Chezal JM; Miot-Noirault E; D'Incan M; Durando X; Cachin F
BMC Cancer; 2022 Apr; 22(1):417. PubMed ID: 35428211
[TBL] [Abstract][Full Text] [Related]
6. Theranostic Approach for Metastatic Pigmented Melanoma Using ICF15002, a Multimodal Radiotracer for Both PET Imaging and Targeted Radionuclide Therapy.
Rbah-Vidal L; Vidal A; Billaud EM; Besse S; Ranchon-Cole I; Mishellany F; Perrot Y; Maigne L; Moins N; Guerquin-Kern JL; Degoul F; Chezal JM; Auzeloux P; Miot-Noirault E
Neoplasia; 2017 Jan; 19(1):17-27. PubMed ID: 27987437
[TBL] [Abstract][Full Text] [Related]
7. In vivo efficacy of melanoma internal radionuclide therapy with a 131I-labelled melanin-targeting heteroarylcarboxamide molecule.
Degoul F; Borel M; Jacquemot N; Besse S; Communal Y; Mishellany F; Papon J; Penault-Llorca F; Donnarieix D; Doly M; Maigne L; Miot-Noirault E; Cayre A; Cluzel J; Moins N; Chezal JM; Bonnet M
Int J Cancer; 2013 Sep; 133(5):1042-53. PubMed ID: 23404099
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma.
Joyal JL; Barrett JA; Marquis JC; Chen J; Hillier SM; Maresca KP; Boyd M; Gage K; Nimmagadda S; Kronauge JF; Friebe M; Dinkelborg L; Stubbs JB; Stabin MG; Mairs R; Pomper MG; Babich JW
Cancer Res; 2010 May; 70(10):4045-53. PubMed ID: 20442292
[TBL] [Abstract][Full Text] [Related]
9. Targeting DNA repair by coDbait enhances melanoma targeted radionuclide therapy.
Viallard C; Chezal JM; Mishellany F; Ranchon-Cole I; Pereira B; Herbette A; Besse S; Boudhraa Z; Jacquemot N; Cayre A; Miot-Noirault E; Sun JS; Dutreix M; Degoul F
Oncotarget; 2016 Mar; 7(11):12927-36. PubMed ID: 26887045
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in Vivo Evaluation of [123I]Melanin-Targeted Agents.
Roberts MP; Nguyen V; Ashford ME; Berghofer P; Wyatt NA; Krause-Heuer AM; Pham TQ; Taylor SR; Hogan L; Jiang CD; Fraser BH; Lengkeek NA; Matesic L; Gregoire MC; Denoyer D; Hicks RJ; Katsifis A; Greguric I
J Med Chem; 2015 Aug; 58(15):6214-24. PubMed ID: 26177000
[TBL] [Abstract][Full Text] [Related]
11. Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52.
Mier W; Kratochwil C; Hassel JC; Giesel FL; Beijer B; Babich JW; Friebe M; Eisenhut M; Enk A; Haberkorn U
J Nucl Med; 2014 Jan; 55(1):9-14. PubMed ID: 24277756
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Targeted Radionuclide Therapy Using [
Akil H; Quintana M; Raymond JH; Billoux T; Benboubker V; Besse S; Auzeloux P; Delmas V; Petit V; Larue L; D'Incan M; Degoul F; Rouanet J
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33804655
[TBL] [Abstract][Full Text] [Related]
13. Targeted radiotherapy of pigmented melanoma with
Xu X; Yuan L; Gai Y; Liu Q; Yin L; Jiang Y; Wang Y; Zhang Y; Lan X
J Exp Clin Cancer Res; 2018 Dec; 37(1):306. PubMed ID: 30537980
[TBL] [Abstract][Full Text] [Related]
14. Radiolabeled melanin-binding peptides are safe and effective in treatment of human pigmented melanoma in a mouse model of disease.
Dadachova E; Moadel T; Schweitzer AD; Bryan RA; Zhang T; Mints L; Revskaya E; Huang X; Ortiz G; Nosanchuk JS; Nosanchuk JD; Casadevall A
Cancer Biother Radiopharm; 2006 Apr; 21(2):117-29. PubMed ID: 16706632
[TBL] [Abstract][Full Text] [Related]
15. [
Rizzo-Padoin N; Chaussard M; Vignal N; Kotula E; Tsoupko-Sitnikov V; Vaz S; Hontonnou F; Liu WQ; Poyet JL; Vidal M; Merlet P; Hosten B; Sarda-Mantel L
Nucl Med Biol; 2016 Dec; 43(12):773-780. PubMed ID: 27693672
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, radiolabeling and preliminary in vivo evaluation of multimodal radiotracers for PET imaging and targeted radionuclide therapy of pigmented melanoma.
Billaud EM; Maisonial-Besset A; Rbah-Vidal L; Vidal A; Besse S; Béquignat JB; Decombat C; Degoul F; Audin L; Deloye JB; Dollé F; Kuhnast B; Madelmont JC; Tarrit S; Galmier MJ; Borel M; Auzeloux P; Miot-Noirault E; Chezal JM
Eur J Med Chem; 2015 Mar; 92():818-38. PubMed ID: 25637883
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of a novel radioiodinated phenylacetamide and its homolog as theranostic agents for malignant melanoma.
Chang CC; Chang CH; Shen CC; Chen CL; Liu RS; Lin MH; Wang HE
Eur J Pharm Sci; 2016 Jan; 81():201-9. PubMed ID: 26517961
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of ¹²³/¹³¹I-Iochlonicotinamide as a novel SPECT probe for malignant melanoma.
Chang CC; Chang CH; Shen CC; Chen CL; Liu RS; Lin MH; Wang HE
Bioorg Med Chem; 2015 May; 23(9):2261-9. PubMed ID: 25800432
[TBL] [Abstract][Full Text] [Related]
19. Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma.
Eaton BR; Kim HS; Schreibmann E; Schuster DM; Galt JR; Barron B; Kim S; Liu Y; Landry J; Fox T
J Vasc Interv Radiol; 2014 Feb; 25(2):288-95. PubMed ID: 24269792
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, radioiodination and in vivo screening of novel potent iodinated and fluorinated radiotracers as melanoma imaging and therapeutic probes.
Maisonial A; Billaud EM; Besse S; Rbah-Vidal L; Papon J; Audin L; Bayle M; Galmier MJ; Tarrit S; Borel M; Askienazy S; Madelmont JC; Moins N; Auzeloux P; Miot-Noirault E; Chezal JM
Eur J Med Chem; 2013 May; 63():840-53. PubMed ID: 23603044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
